MAGE-A4ᶜ¹º³²T for Multi-Tumor

Conditions:   Bladder Cancer;   Melanoma;   Head and Neck Cancer;   Ovarian Cancer;   Non-Small Cell Lung Cancer;   Esophageal Cancer;   Gastric Cancer
Intervention:   Genetic: Autologous genetically modified MAGE-A4ᶜ¹º³²T cells
Sponsor:   Adaptimmune
Not yet recruiting - verified April 2017

http://ift.tt/2qeEPfT